Delivery Order SPE2DR25D2014-SPE2DR26FZ92P
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,093.31 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal military...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,622.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on November 28, 2025, with an ultimate completion date of December 1, 2025. This award is a non-set-aside contract and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $2,948.88 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.47 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on November 7, 2025, with completion targeted for November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,708.70 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray (2-count units). This competitive delivery order, issued on December 27, 2025, with an ultimate completion date of December 29, 2025, represents a firm fixed-price transaction with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.20 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,033.92 firm fixed price delivery order for Naloxone HCL 4 mg nasal spray on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitive award, which carries no set-aside designation, represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a $3,712.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) with an ultimate completion date of August 1, 2025. This non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.79 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-spray units). The contract carries a firm fixed price and is scheduled for completion by December 12, 2025, with performance to take place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's established capability...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ92PDelivery Order
The Defense Logistics Agency awarded a $3,834.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-dose units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This delivery order operates under AmerisourceBergen's significant $999.99 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The naloxone procurement supports emergency medical supply requirements for opioid overdose reversal, reflecting the federal government's broader initiatives to maintain critical pharmaceutical inventories across military and veteran healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 12/9/25 |